Cassava sciences reports full-year 2021 financial results and operating updates

Austin, texas, feb. 28, 2022 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a clinical-stage biotechnology company focused on alzheimer's disease, today announced financial results for the year ended december 31, 2021 and provided clinical and business updates.

SAVA Ratings Summary

SAVA Quant Ranking